Bill Text: NY S04870 | 2021-2022 | General Assembly | Amended
Bill Title: Relates to the definition of the practice of pharmacy.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Passed) 2022-12-28 - APPROVAL MEMO.87 [S04870 Detail]
Download: New_York-2021-S04870-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 4870--B Cal. No. 1238 2021-2022 Regular Sessions IN SENATE February 17, 2021 ___________ Introduced by Sens. BRESLIN, ADDABBO -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- recommitted to the Committee on Higher Education in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the education law, in relation to the definition of the practice of pharmacy The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 22 of section 6802 of the education law, as 2 amended by chapter 555 of the laws of 2021, is amended to read as 3 follows: 4 22. "Administer", for the purpose of section sixty-eight hundred one 5 of this article, means: 6 a. (1) the direct application of an immunizing agent to adults, wheth- 7 er by injection, ingestion, inhalation or any other means, pursuant to a 8 patient specific order or non-patient specific regimen prescribed or 9 ordered by a physician or certified nurse practitioner, for: immuniza- 10 tions to prevent influenza, pneumococcal, acute herpes zoster, hepatitis 11 A, hepatitis B, human papillomavirus, measles, mumps, rubella, varicel- 12 la, COVID-19, meningococcal, tetanus, diphtheria or pertussis disease 13 and medications required for emergency treatment of anaphylaxis; and 14 other immunizations recommended by the advisory committee on immuniza- 15 tion practices of the centers for disease control and prevention for 16 patients eighteen years of age or older if the commissioner of health in 17 consultation with the commissioner determines that an immunization: 18 (i)(A) may be safely administered by a licensed pharmacist within their 19 lawful scope of practice; and (B) is needed to prevent the transmission EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD03519-09-2S. 4870--B 2 1 of a reportable communicable disease that is prevalent in New York 2 state; or (ii) is a recommended immunization for such patients who: (A) 3 meet age requirements, (B) lack documentation of such immunization, (C) 4 lack evidence of past infection, or (D) have an additional risk factor 5 or another indication as recommended by the advisory committee on immun- 6 ization practices of the centers for disease control and prevention. If 7 the commissioner of health determines that there is an outbreak of 8 disease, or that there is the imminent threat of an outbreak of disease, 9 then the commissioner of health may issue a non-patient specific regimen 10 applicable statewide. 11 [b.] (2) the direct application of an immunizing agent to children 12 between the ages of two and eighteen years of age, whether by injection, 13 ingestion, inhalation or any other means, pursuant to a patient specific 14 order or non-patient specific regimen prescribed or ordered by a physi- 15 cian or certified nurse practitioner, for immunization to prevent influ- 16 enza and medications required for emergency treatment of anaphylaxis 17 resulting from such immunization. If the commissioner of health deter- 18 mines that there is an outbreak of influenza, or that there is the immi- 19 nent threat of an outbreak of influenza, then the commissioner of health 20 may issue a non-patient specific regimen applicable statewide. 21 b. The injection of medications into the deltoid muscle for the treat- 22 ment of mental health and substance use disorder, as prescribed or 23 ordered by a licensed prescriber, acting within the scope of their prac- 24 tice in this state and in accordance with regulations promulgated by the 25 commissioner and the department of health in consultation with any other 26 state agencies as necessary, but not be limited to, providing that: 27 (1) Such administration is conducted pursuant to a valid prescription 28 or order that authorizes a pharmacist to administer medications for the 29 treatment of mental health and substance use disorder and the pharmacist 30 notifies the licensed prescriber that the administration is complete. 31 Administration in a pharmacy may not commence until after the patient 32 has received the initial injection and is considered eligible for main- 33 tenance treatment by the licensed prescriber. 34 (2) Such prescription may be subject to reassessment at appropriate 35 intervals, as determined by the licensed prescriber. 36 (3) Such activity is conducted in accordance with regulations, promul- 37 gated or adopted by the commissioner and the department of health, in 38 consultation with any other state agencies, as necessary, which shall 39 include requirements for the following: 40 (i) Training accredited by the accreditation council for pharmacy 41 education, that may include educational experiences obtained through 42 pharmacy school curricula, or a similar health authority or professional 43 body appropriate for the medications being administered and their 44 respective patient populations. Such training must be satisfactory to 45 the commissioner and the department of health, in consultation with the 46 board of pharmacy and any other state agencies, as necessary, which 47 shall include, but not be limited to learning modules on techniques for 48 administration by injections, indications, precautions, and contraindi- 49 cations in the use of agent or agents; record keeping and information; 50 and handling emergencies, including anaphylaxis, needle-sticks and 51 cardiopulmonary resuscitation. 52 (ii) Maintaining continued competency regarding the populations served 53 and medications administered. 54 (iii) Pre-administration patient consent and education regarding 55 common side effects, drug interactions, injection site reactions and 56 other information routinely provided to patients upon dispensing. If aS. 4870--B 3 1 patient is unable to provide consent, the pharmacist must obtain consent 2 from a person legally responsible when the recipient is incapable of 3 consenting. 4 (iv) When administering an injection in a pharmacy, the pharmacist 5 shall provide an area for the injection that provides for the patient's 6 privacy. 7 (v) Record keeping and reporting of such administration by electronic 8 transmission or facsimile to the patient's licensed prescriber, and, to 9 the extent practicable, make himself or herself available to discuss the 10 outcome of such injection, including any adverse reactions, with the 11 licensed prescriber acting within their scope of practice. 12 § 2. Section 6801 of the education law is amended by adding a new 13 subdivision 8 to read as follows: 14 8. A licensed pharmacist within their lawful scope of practice may 15 administer injectable medications into the deltoid muscle, pursuant to 16 section six thousand eight hundred two of this article, for the treat- 17 ment of mental health and substance use disorder, as prescribed or 18 ordered by a licensed prescriber, acting within their scope of practice 19 in this state and in accordance with regulations, including but not 20 limited to regulations promulgated by the commissioner in consultation 21 with any other state agencies, as necessary. 22 § 3. This act shall take effect one year after it shall have become a 23 law. Effective immediately, the addition, amendment and/or repeal of any 24 rule or regulation necessary for the implementation of this act on its 25 effective date are authorized to be made and completed by the commis- 26 sioner of education on or before such date.
